Nplate 500 MCG vials
Ended Awarded
- Contract number
- SPE2DB25FKEKQ
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $6,697
Award facts
- Contract value 100% obligated
- $6,697.06 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $6,697.06 by the Defense Logistics Agency (DLA) on August 25, 2025, for the supply of Nplate 500 microgram vials. This firm fixed-price delivery order is part of DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, a $500 million vehicle valid through November 2026 that enables the agency to procure comprehensive pharmaceutical products and medical supplies for Department of Defense healthcare facilities worldwide. The contract award carries no set-aside designation, and the ultimate completion date is scheduled for September 16, 2025, with performance taking place at the contractor's location in Park Ridge, Illinois.
As a critical supplier in the federal pharmaceutical supply chain, DMS Pharmaceutical Group has consistently secured multiple delivery orders from the DLA covering a broad portfolio of medical products including prescription medications, biologics, vaccines, and specialty pharmaceuticals. The company's established presence in federal procurement since 2001 and its status as a woman-owned small business have enabled it to compete effectively and serve as a primary distributor of pharmaceutical products to military health facilities. This delivery order for Nplate, a thrombopoietin receptor agonist used to treat thrombocytopenia, represents one of many specialized pharmaceutical items the contractor delivers to support the Department of Defense's healthcare operations.
Quick answers
Who was awarded contract SPE2DB25FKEKQ?
SPE2DB25FKEKQ was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 25, 2025.
How much is contract SPE2DB25FKEKQ worth?
The government has obligated $6,697 on SPE2DB25FKEKQ.
Is contract SPE2DB25FKEKQ an order under another contract?
Yes. SPE2DB25FKEKQ is a delivery order under SPE2DB24D9223, an indefinite delivery contract.
Was contract SPE2DB25FKEKQ competed?
The extent of competition for SPE2DB25FKEKQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award